NCT03225482

Brief Summary

The number of older Veterans with Mild Cognitive Impairment (MCI) seeking care within the Veterans Affairs (VA) health care system is increasing and is expected to increase more rapidly as Vietnam era Veterans age. The cognitive effects of MCI and subsequent neurodegenerative disorders can adversely affect a Veteran's ability to function independently and failure to provide appropriate intervention can result in an increased need for healthcare services and VA benefits in the future. The VA currently spends over $19,000 annually per patient to care for Veterans with dementia (Zhu et al., 2009), and delaying the onset of dementia even by one to two years will result in substantial financial savings to the VA and quality of life gains for the Veteran. Since present pharmacological interventions have demonstrated limited efficacy, alternative treatments are needed. Therefore, an evidence-based cognitive training intervention that optimally addresses the needs of older Veterans with MCI is of critical importance to the VA patient care mission.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
193

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 7, 2017

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 21, 2017

Completed
12 months until next milestone

Study Start

First participant enrolled

July 11, 2018

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

August 11, 2025

Completed
Last Updated

August 11, 2025

Status Verified

August 1, 2025

Enrollment Period

6 years

First QC Date

July 7, 2017

Results QC Date

June 20, 2025

Last Update Submit

August 7, 2025

Conditions

Keywords

Mild Cognitive ImpairmentCognitive rehabilitationCognitive trainingCognitive remediation

Outcome Measures

Primary Outcomes (2)

  • Change in Objective Cognitive Performance Composite z Score

    Change in composite z score on the following tests: Hopkins Verbal Learning Test-Revised (HVLT-R) Brief Visuospatial Memory Test-Revised (BVMT-R) Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV) Digit Span WAIS-IV Coding Delis-Kaplan Executive Function System (D-KEFS) Trails, Number and Letter Sequencing D-KEFS Trails, Number-Letter Switching D-KEFS Color-Word Interference Test, Inhibition and Inhibition-Switching A Z score of 0 represents the sample mean. Higher composite Z scores reflect better performance.

    assessed at baseline, 8 weeks, 21 weeks; change from baseline to 21 weeks reported.

  • Change in Functional Capacity Performance Composite z Score

    Change in composite z score on the following measures: UCSD Performance-Based Skills Assessment-Brief (UPSA-B) Medication Management Ability Assessment (MMAA) Neuropsychological Assessment Battery Daily Living Memory Neuropsychological Assessment Battery Judgment Neuropsychological Assessment Battery Driving Scenes A Z score of 0 represents the sample mean. Higher Z scores reflect better performance.

    assessed at baseline, 8 weeks, 21 weeks; change from baseline to 21 weeks reported.

Secondary Outcomes (7)

  • Change in Subjective Everyday Functioning Composite Score

    assessed at baseline, 4 weeks, 8 weeks, 21 weeks; change from baseline to 21 weeks reported.

  • Change in Everyday Cognition Scale

    assessed at baseline, 4 weeks, 8 weeks, 21 weeks; change from baseline to 21 weeks reported.

  • Change in Cognitive Activity Inventory

    assessed at baseline, 4 weeks, 8 weeks, 21 weeks; change from baseline to 21 weeks reported.

  • Change in CHAMPS Physical Activity Questionnaire for Older Adults

    assessed at baseline, 4 weeks, 8 weeks, 21 weeks; change from baseline to 21 weeks reported.

  • Change in Portland Cognitive Strategies Scale

    assessed at baseline, 4 weeks, 8 weeks, 21 weeks; change from baseline to 21 weeks reported.

  • +2 more secondary outcomes

Study Arms (2)

ME-CCT

EXPERIMENTAL

8-week Motivationally Enhanced Compensatory Cognitive Training group

Behavioral: Motivationally Enhanced Compensatory Cognitive Training

SC

ACTIVE COMPARATOR

8-week Goal-focused Supportive Contact group

Behavioral: Goal-focused Supportive Contact

Interventions

ME-CCT is a manualized group-based behavioral intervention (8 weeks, 2 hours per week, 20 hours total) designed to improve cognitive and everyday functioning in patients with MCI.

Also known as: ME-CCT
ME-CCT

SC is a group therapy intervention that provides the same frequency and amount of therapist and other group member contact as ME-CCT, but does not provide training in cognitive strategies, lifestyle strategies, or motivational enhancement. The SC intervention focuses on setting and achieving short or long-term goals.

Also known as: SC
SC

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Veterans \>55 years old enrolled at one of the participating VA sites (VASDHS and VAPORHCS) who are able to provide informed consent
  • Independently living
  • Meet criteria for MCI based on previously published criteria (see below)
  • Willingness to participate in audio-recorded sessions.
  • MCI Criteria:
  • Concern about a decline in cognitive functioning expressed by a physician, informant, participant or nurse
  • Cognitive impairment in one or more of the following domains
  • executive function
  • memory
  • attention
  • language or visuospatial abilities
  • Normal or minimal impairment in functional activities
  • Does not meet criteria for dementia

You may not qualify if:

  • Current substance use disorder with \< 30 days abstinence
  • History of schizophrenia, schizoaffective disorder, or other primary psychotic disorder
  • History of significant brain injury with loss of consciousness \> 30 minutes
  • Auditory or visual impairments that would prevent ability to participate in the cognitive rehabilitation group or benefit from compensatory strategies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

VA San Diego Healthcare System, San Diego, CA

San Diego, California, 92161-0002, United States

Location

VA Portland Health Care System, Portland, OR

Portland, Oregon, 97239, United States

Location

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Results Point of Contact

Title
Elizabeth Twamley, PhD
Organization
VA San Diego Healthcare System

Study Officials

  • Elizabeth W. Twamley, PhD

    VA San Diego Healthcare System, San Diego, CA

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcomes assessors will be blind to treatment group assignment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two group randomized controlled trial.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 7, 2017

First Posted

July 21, 2017

Study Start

July 11, 2018

Primary Completion

June 30, 2024

Study Completion

June 30, 2024

Last Updated

August 11, 2025

Results First Posted

August 11, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations